Charlotte Beaudart, Namuroise of the Year: reward for her research on ageing
Helping us to age independently and in good health. This is the aim of Charlotte Beaudart's research into sarcopenia, an age-related disease that can occur as early as the age of 50. The work of the UNamur researcher and member of the Narilis Institute has been rewarded once again, as she has just been awarded the title of "Namuroise of the Year", for the Sciences category!
See content
Guillaume Berionni receives the CRS Triennial Award
In October 2024, Guillaume Berionni, a researcher in the Department of Chemistry at the University of Namur, received the Royal Society of Chemistry's (RSC) triennial prize from its President, Professor Anne-Sophie Duwez. A fine reward for his research team in organometallic reactivity and catalysis (RCO), but also for our institution and its Department of Chemistry.
See content
Skin infections: UNamur partners in Win²WAL research project
The TineaDiag project is a research project run by UNamur and ULiège with funding from the SPW Research Win²WAL program. It tackles dermatophytoses, skin infections responsible for ringworm, which can affect both humans and animals. The aim? To identify, in dermatophytes, precise cellular markers in order to detect them with sensitivity and certainty, and thus identify infections caused by antifungal-resistant strains.
See content
Quantum chemistry at the University of Sfax thanks to the ERASMUS+ program
A practical training course in computational quantum chemistry was organized from May 26 to 30, 2025 as part of an ERASMUS+ collaboration between the University of Sfax and the University of Namur. This inter-university training course for PhD students in chemistry and physics from the Tunisian University brought together more than 20 students.
See content
Public defense of doctoral thesis in Physical Sciences - Andrea Scarmelotto
Abstract
Radiotherapy is a cornerstone of cancer treatment and is currently administered to approximately half of all cancer patients. However, the cytotoxic effects of ionizing radiation on normal tissues represent a major limitation, as they restrict the dose that can be safely delivered to patients and, consequently, reduce the likelihood of effective tumor control. In this context, delivering radiation at ultra-high dose rates (UHDR, > 40 Gy/s) is gaining increasing attention due to its potential to spare healthy tissues surrounding the tumor and to prevent radiation-induced side effects, as compared to conventional dose rates (CONV, on the order of Gy/min).The mechanism underlying this protective effect-termed the FLASH effect-remains elusive, driving intensive research to elucidate the biological processes triggered by this type of irradiation.In vitro models offer a valuable tool to support this research, allowing for the efficient screening of various beam parameters and biological responses in a time- and cost-effective manner. In this study, multicellular tumor spheroids and normal cells were exposed to proton irradiation at UHDR to evaluate its efficacy in controlling tumor growth and its cytotoxic impact on healthy tissues, respectively.We report that UHDR and CONV irradiation induced a comparable growth delay in 3D tumor spheroids, suggesting similar efficacy in tumor control. In normal cells, both dose rates induced similar levels of senescence; however, UHDR irradiation led to lower apoptosis induction at clinically relevant doses and early time points post-irradiation.Taken together, these findings further highlight the potential of UHDR irradiation to modulate the response of normal tissues while maintaining comparable tumor control.JuryProf. Thomas BALLIGAND (UNamur), PresidentProf. Stéphane LUCAS (UNamur), SecretaryProf. Carine MICHIELS (UNamur)Dr Sébastien PENNINCKX (Hôpital Universitaire de Bruxelles)Prof. Cristian FERNANDEZ (University of Bern)Dr Rudi LABARBE (IBA)
See content
The Department of Physics welcomes a delegation from CERN
In May 2025, the Department of Physics welcomed two special visitors: Serge Mathot and François Briard from Namur, both alumni of UNamur and members of CERN. Several activities were on the program, ranging from a visit to the particle accelerator, to science popularization and thematic seminars, particularly in heritage sciences. The aim? To identify areas or activities in which UNamur and CERN could strengthen their collaboration.
See content
Understanding cell migration to fight cancer
When a tumour develops in an organism, it is very common for the cancer cells to leave the tumour and move to another organ where they proliferate, creating what are known as metastases. This process is an important factor in mortality, as it means that the disease worsens. Hence the interest in better understanding what happens during this phenomenon. This is what the multidisciplinary team of Carine Michiels, researcher at the NARILIS Institute of UNamur, and Davide Bonifazi, researcher at the University of Vienna, did in the framework of the PACMAN research project financed by the FNRS. The results of this study are published in the journal Neoplasia.
See content
Michaël Lobet, the physicist of the invisible who twists light
Let's go and discover the qualified researchers of UNamur, winners of the funding granted by the FNRS in 2022. Today, we meet Michaël Lobet, currently a lecturer at UNamur, who will begin his new mandate as a qualified FNRS researcher at the NISM Institute next fall. The subject of his research: twisted optics for the manipulation of slow photons or how to create light traps. Explanations.
See content
Carine Michiels receives the ERRS Bacq and Alexander Award
Since 1996, the European Radiation Research Society (ERRS) has awarded the Bacq and Alexander Prize each year to an outstanding European researcher in recognition of the recipient's achievements in the field of radiation research. This year, the award was presented to Professor Carine Michiels, from the University of Namur.
See content
Lysosome: from protein transport to bone remodelling
The lysosome, a small intracellular organelle, is often represented as the stomach of the cell due to its acidity and the presence of numerous digestive enzymes within it. Its role? The degradation of numerous molecules and their recycling to build new molecules and fuel energy production in the cells. Since 2003, Marielle Boonen has been particularly interested in the lysosome. Together with researchers from UNamur, she has highlighted the role of a lysosomal enzyme called HYAL1 in the bone remodelling process.
See content